Denver submits public comment for federal rescheduling of marijuana
Published on July 17, 2024
The following statement is from Denver Office of Marijuana Policy and Department of Excise and Licenses Executive Director Molly Duplechian after the submission of public comment by the City and County of Denver to the federal Department of Justice for consideration of rescheduling marijuana from a Schedule I to a Schedule III drug.
"We've learned after more than a decade of legalized medical and retail marijuana in Denver that marijuana does not rise to the level of a Schedule I substance - a classification reserved for drugs like heroin, LSD, and ecstasy. Marijuana offers some medical benefits that require further research and study, which is severely restricted by its current classification."
"The industry employs thousands of people across Denver and the United States and has contributed millions of dollars in tax revenue. And in Denver, the industry has kept its promise to successfully prevent a surge in youth usage. As the industry currently experiences a recession, normal tax deductions that other industries currently enjoy will be possible under a rescheduling. This is essential so marijuana businesses can continue to be a contributor to our economic prosperity. This aspect of rescheduling could also result in more avenues for people most negatively impacted by marijuana prohibition to have a pathway to participate as cannabis business owners."
"As the executive director of the agency overseeing marijuana licensing, I believe it's important to recognize Denver as the most experienced marijuana-regulated city in the world that created a regulatory plan copied across America. It is not sound policy to continue to classify marijuana as a Schedule I substance. That said, the details of how the federal government implements this change is critical. Attention should be given to ensure local jurisdictions maintain the ability to quickly respond to public health risks related to marijuana. Local revenue generated from marijuana sales tax and licensing fees and adequate access to medical marijuana for patients should not be disturbed."
Here is an online link to the public comment submitted by the City and County of Denver. The deadline for public comment is July 22.